Opus Genetics, Inc.
NASDAQ:IRDBiotechnology
-$0.01 today
- Market cap
- $326.13M
- Beta
- 0.55
- P/E (TTM)
- -33.0
- EPS (TTM)
- -$0.12
Volume 0.75M
Average 0.81M
IRD Total Debt
Short-term and long-term borrowings combined.
Opus Genetics, Inc.NASDAQ: IRD
Total Debt · Q1 FY2026 · quarter ended Mar 2026
Total debt remains negative
Q1 FY2026 total debt was $25.93M, compared with $0 a year earlier.
Context
- Total debt amounted to 38.8% of total assets at the end of Q1 FY2026, up 38.8 pp from a year earlier.
- Total debt increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Debt history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Total Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | -100.0% |
| FY2021 | 2021-12-31 | 538K | — |
Total Debt vs competitors
How IRD compares with its peers on the latest reported figures
- IRD's Mar 2026 total debt of $25.93M is the 6th highest of the 10 companies compared; the peer median is $31.16M.
- Total debt amounts to 38.8% of total assets for IRD, versus a peer median of 17.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $304.46M | +230.8% | +62.2% | 163.3% | |
| Mar 2026 | $85.19M | -1.7% | +2.2% | 42.5% | |
| Mar 2026 | $80.5M | -10.1% | -20.1% | 68.4% | |
| Mar 2026 | $34.55M | -15.8% | -5.8% | 14.4% | |
| Mar 2026 | $31.16M | +7.5% | +568.1% | 23.3% | |
IRDOpus Genetics, Inc. | Mar 2026 | $25.93M | — | — | 38.8% |
| Mar 2026 | $23.03M | -9.4% | -7.5% | 8.5% | |
| Mar 2026 | $8.7M | -22.9% | -33.7% | 17.5% | |
| Mar 2026 | $465K | -26.8% | -24.4% | 1.3% | |
| Mar 2026 | $456.93K | +177.6% | +71.7% | 1.5% | |
| Peer median (excluding IRD) | $31.16M | -9.4% | -5.8% | 17.5% | |
Competitors are the stored peer set for IRD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Opus Genetics, Inc.
NASDAQ:IRD
Intrinsic Alpha fair value
Locked
Current Price
$3.92
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.